Dissecting the role of SALL4, a newly identified stem cell factor, in chronic myelogenous leukemia
Open Access
- 5 April 2011
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 25 (7), 1211-1213
- https://doi.org/10.1038/leu.2011.65
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemiaBlood, 2007
- Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cellsProceedings of the National Academy of Sciences, 2007
- SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic miceBlood, 2006
- Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1Nature Cell Biology, 2006
- Granulocyte–Macrophage Progenitors as Candidate Leukemic Stem Cells in Blast-Crisis CMLNew England Journal of Medicine, 2004
- Self-renewal of hematopoietic and leukemic stem cells: a central role for the Polycomb-group gene Bmi-1Trends in Immunology, 2003
- Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cellsNature, 2003
- The P190, P210, and P230 Forms of the BCR/ABL Oncogene Induce a Similar Chronic Myeloid Leukemia–like Syndrome in Mice but Have Different Lymphoid Leukemogenic ActivityThe Journal of Experimental Medicine, 1999